GLP-1 weight-loss drugs cut calorie intake 21% and grocery spending 5–6%, reshaping food demand

GLP-1 weight-loss drugs such as semaglutide are linked to lower calorie intake and smaller grocery bills, with users cutting spending by roughly 5–6%. Clinical evidence indicates consumers tend to reduce high-emissions foods first, including red meat and sugary drinks. In the U.S., USDA data show softer corn and soybean planting projections and a cattle herd at a 75-year low, as the shift shows up in both corporate earnings and agricultural indicators.